HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Fertility preservation must be an ‘integral part’ of early cancer care
-
- AACI awards four fellowships
- ASCO presents humanitarian award
- CMS announces final rule for stage 2 implementation of EHRs
- Endocrine Society releases practice improvement module focused on thyroid nodules
- Imaging agent designed to detect recurrent prostate cancer
- Neuro-oncologist joins NYU center
- Patients with myeloproliferative neoplasms continue to have significantly reduced life expectancy
- Professors receive grants from NCI
-
- SORT OUT III: SES beat out ZES in MACE, but posed higher risk for very late definite stent thrombosis
- A pregnant 40-year-old with possible hemophilia carrier status Tim McCarthy, MD
- FDA approves orphan drug for CML
- Adding aspirin to clopidogrel failed to prevent recurrent strokes
- Addition of enzastaurin to erlotinib did not improve survival in NSCLC
- Basal cell carcinoma recurred aggressively after photodynamic therapy
- Bevacizumab and pegylated liposomal doxorubicin linked to activity, toxicity
- Biologic therapy for patients with rheumatoid arthritis not linked to increased malignancy risk
-
- Blood clot removal device shows potential for patients with ischemic stroke
- CDC: Public health initiatives should promote walking
- Clinical model predicted pathCR with higher probability
- Clinician recommendation positively linked to male vaccination against HPV
- Consensus statements developed for managing Barrett's esophagus
- Cytotoxic chemotherapy helped to induce, maintain IBD remission
- Drug improved remission rates in patients with AML
- Eltrombopag trial halted after thrombotic events in patients with liver disease, thrombocytopenia
-
- Enzalutamide prolonged survival in castration-resistant prostate cancer after chemotherapy
- Focus should shift to multiple diseases contributing to deaths among older adults
- Gene loss in ovarian cancer subtype linked to chemotherapy resistance
- Imatinib plus chemotherapy may benefit children with Ph+ALL
- Incidence of esophageal adenocarcinoma increasing dramatically worldwide
- Injection drug use, blood transfusions biggest risk factors for hepatitis C
- Intervention helped children complete MRI without sedation
- Liver transplant may be an option for some patients with unresectable HCC
-
- Mutation may help differentiate rare lymphomas from other B-cell disorders
- Obesity linked to poorer outcomes in HR-positive breast cancer
- Relapse therapy associated with improved survival in ovarian cancer
- Researchers find mechanism that promotes cancer treatment resistance
- Substantial pathological differences between HCC patients with HBV, HCV
- Ticagrelor results consistent regardless of smoking status
- Trastuzumab linked to elevated risk for HF, cardiomyopathy
- 21-gene recurrence score may predict outcomes in ER-positive, node-positive patients
-
- Addition of everolimus improved PFS in postmenopausal patients
- Challenges remain in reaching 100% cure rate in HCV
- Device may reduce re-excision rate in breast cancer surgery
- Everolimus linked to significant clinical benefit in ER-positive breast cancer
- IOERT delivered safely in early, low-risk disease
- IORT may yield significant savings over other approaches
- Mortality related to C. difficile 2.5 times higher than controls
- Multicatheter brachytherapy linked to long-term disease control rates
-
- Novel therapy improved PFS for patients with advanced breast cancer
- Pooled analysis showed excellent outcomes after surgery, APBI
- Research raises questions about expensive staging modalities